![Birgit Jung](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Birgit Jung
Entité | Type d'entité | Industrie | |
---|---|---|---|
HepaRegeniX GmbH
![]() HepaRegeniX GmbH Miscellaneous Commercial ServicesCommercial Services HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany.
7
| Holding Company | Miscellaneous Commercial Services | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Birgit Jung via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
NOVO NORDISK A/S | Pharmaceuticals: Major | Sales & Marketing | |
Novo Nordisk Pharma GmbH
![]() Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Pharmaceuticals: Major | Sales & Marketing | |
Calliditas Therapeutics Suisse SA
![]() Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Generic | Chief Executive Officer | |
MEDIGENE AG | Biotechnology | Corporate Officer/Principal | |
Novo Holdings AS (Denmark)
![]() Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Financial Conglomerates | Corporate Officer/Principal | |
Auriga Partners SA
![]() Auriga Partners SA Investment ManagersFinance Auriga Partners SA (Auriga) is an independent, management-owned venture capital firm which was founded by Patrick Bamas, Jacques Chatain and Bernard Daugeras in 1998. Headquartered in Paris, the firm's core activity is enterprise creation. In addition to providing a network of contacts capable of accelerating internationalization, and furthering strategic partnerships and business deals, Auriga manages several seed and early-stage funds specializing in information technology and life sciences. | Investment Managers | Director of Investments | |
Ithaca College | College/University | Undergraduate Degree | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree | |
University of Maine | College/University | Doctorate Degree | |
FLERIE INVEST AB | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Philip Morris USA, Inc.
![]() Philip Morris USA, Inc. TobaccoConsumer Non-Durables Philip Morris USA, Inc. makes and markets tobacco goods. Its products include cigarette non-tobacco, cigarette tobacco and flavor ingredients. The company was founded by Philip Morris in 1847 and is headquartered in Richmond, VA. | Tobacco | Corporate Officer/Principal | |
University of Gottingen | College/University | Corporate Officer/Principal | |
University of Hohenheim | College/University | Undergraduate Degree | |
ESCP Europe Campus Paris | College/University | Graduate Degree | |
Omnes Capital SAS /Venture/
![]() Omnes Capital SAS /Venture/ Investment ManagersFinance Omnes Capital SAS /Venture/ is a Venture Capital firm, a subsidiary of Omnes Capital SAS founded in 1999. Omnes Capital /Venture/ is headquartered in Paris. | Investment Managers | Private Equity Investor | |
HELIAD AG | Investment Managers | Chief Executive Officer | |
Waterland Private Equity GmbH | Investment Managers | President | |
Landesbank Baden-Württemberg (Broker)
![]() Landesbank Baden-Württemberg (Broker) Investment Banks/BrokersFinance Landesbank Baden-Württemberg (Broker) (LBBW-Broker) is the brokerage division of Landesbank Baden-Württemberg in Germany. Headquartered in Stuttgart, the firm was founded in 1999 and provides capital market services to medium-sized companies, listed groups, institutional customers, savings banks and retail customers. | Investment Banks/Brokers | Analyst-Equity | |
Covagen AG
![]() Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Corporate Officer/Principal | |
Novo Seeds
![]() Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor | |
Agrocampus Rennes | College/University | Undergraduate Degree | |
Boehringer Ingelheim (Venture Capital)
![]() Boehringer Ingelheim (Venture Capital) Investment ManagersFinance Boehringer Ingelheim (BIVF) is the venture capital arm of Boehringer Ingelheim International GmbH, itself a subsidiary of C.H. Boehringer Sohn AG & Co. KG. The firm was founded in 2010 and is headquartered in Ingelheim, Germany. It also has two US offices located in Fremont, California, and Cambridge, Massachusetts. | Investment Managers | Private Equity Investor | |
Minervax ApS
![]() Minervax ApS Medical SpecialtiesHealth Technology Minervax ApS provides vaccine against streptococci. It utilizes fusion protein, which has proved to elicit good protective immunity. Its vaccine provides protective immunity against many clinically relevant GBS strains. The firm is engages in biotechnology, scientific and technical activities, and research and development. The company was founded in 2010 and is headquartered in Copenhagen, Denmark. | Medical Specialties | Director/Board Member | |
Pcovery ApS
![]() Pcovery ApS Pharmaceuticals: MajorHealth Technology Pcovery ApS develops drugs for treatment of invasive fungal infections. It discovers a new class of fungal therapy by targeting an essential and highly conserved component of the fungal cell membrane. The company was founded by Morten J. Buch-Pedersen, Michael Broberg Palmgren, Claus Olesen and Poul Nissen in 2009 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Eyevensys SAS
![]() Eyevensys SAS Miscellaneous Commercial ServicesCommercial Services Eyevensys SAS develops non-viral gene therapy process for the treatment of ocular illnesses. The firm's process enables prolonged production of all therapeutic proteins through electrotransfer. Its product, the single-used device is designed for treating ocular illnesses. The company was founded by Francine Behar-Cohen on December 8, 2008 and is headquartered in Paris, France. | Miscellaneous Commercial Services | Director/Board Member | |
THERANEXUS | Pharmaceuticals: Major | Director/Board Member | |
Avilex Pharma ApS
![]() Avilex Pharma ApS Pharmaceuticals: MajorHealth Technology Avilex Pharma ApS develops and produces drugs to treat brain damage with the uses of dimeric ligands. It also develops novel inhibitors to target a range of unmet medical needs. The firm uses dimeric ligands that targets intracellular with unprecedented potency. The company was founded by Kristian Strømgaard and Anders Bach on December 27, 2012 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Kellogg School of Management | College/University | Masters Business Admin | |
CorWave SA
![]() CorWave SA Medical SpecialtiesHealth Technology CorWave SA develops and manufactures blood pumps. The company was founded in 2011 and is headquartered in Paris, France. | Medical Specialties | Director/Board Member | |
Memo Therapeutics AG
![]() Memo Therapeutics AG BiotechnologyHealth Technology Memo Therapeutics AG develops recombinant immunoglobulins and human-derived monoclonal antibodies. Its products include human antibodies, human immune repertoire analysis, classic antibody discovery and pipeline. The company was founded by Christoph Esslinger on November 29, 2012 and is headquartered in Basel, Switzerland. | Biotechnology | Chairman | |
Inthera Bioscience AG
![]() Inthera Bioscience AG BiotechnologyHealth Technology Inthera Bioscience AG engages in the research in as well as development, production, and distribution of pharmaceutical, biological, and other products used in the fields of human and veterinary medicine. It also provides related consultancy services. The company was founded by Ulrich Kessler and Paramjit Singh Arora on September 20, 2013 and is headquartered in Zurich, Switzerland. | Biotechnology | Director/Board Member | |
Centauri Therapeutics Ltd.
![]() Centauri Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Centauri Therapeutics Ltd. engages in manufacturing processing drugs in pharmaceutical preparations for life threatening diseases. The firm focuses on on the discovery and development of novel molecules targeting life threatening diseases. The company was founded by Mike Westby and Stuart Lawson and is headquartered in Sandwich, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
InDex Pharmaceuticals AB
![]() InDex Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology InDex Pharmaceuticals AB is a pharmaceutical development company, which engages in the research, development of technology, and commercialization of scientific discoveries focusing on immunological diseases. It also offers the drug candidate cobitolimod and DiBiCol diagnostic kit. The company was founded was founded on December 14, 2015 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
GENKYOTEX SA. | Pharmaceuticals: Major | Chief Executive Officer | |
Antag Therapeutics ApS
![]() Antag Therapeutics ApS Pharmaceuticals: MajorHealth Technology Antag Therapeutics ApS develops peptide drugs for the treatment of dietary-related metabolic diseases. It develops drugs for obesity, diabetes, and non-alcoholic fatty liver disease. The company was founded by Alexander Sparre-Ulrich and Jens Juul Holst in 2017 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Director/Board Member | |
GTM-Halle SASU
![]() GTM-Halle SASU HomebuildingConsumer Durables Part of VINCI SA, GTM-Halle SASU is a French company founded in 2007 that specializes in construction and technical resources. The company is based in Laxou, France. GTM-Halle has worked on various projects including the construction of Custines College, Bénamenil College, and Decomble de Chaumont Lycée. The company has also been involved in health and medico-social projects such as the construction of Residence Domitys Calliope, EHPAD Korian, and hospital centers. The technical and operational resources department of GTM-Halle integrates all the necessary means to deploy on construction sites from the study phase. | Homebuilding | Chairman | |
AgomAb Therapeutics NV
![]() AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Draupnir Bio ApS
![]() Draupnir Bio ApS Pharmaceuticals: MajorHealth Technology Draupnir Bio ApS engages in the manufacture and distribution of biotechnological and pharmaceutical products. It also provides medical research services. The company was founded on April 4, 2017 and is headquartered in Risskov, Denmark. | Pharmaceuticals: Major | Chairman | |
DiogenX SAS
![]() DiogenX SAS BiotechnologyHealth Technology DiogenX SAS engages in the discovery and development of biologics therapeutics options of Diabetic patients. It operates in Diabetes preclinical stage business segment. The company was founded by Benjamin Charles, Patrick Collombat and Jean Pascal Tranié on December 24, 2019 and is headquartered in Marseille, France. | Biotechnology | Director/Board Member | |
Tribune Therapeutics AB
![]() Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
IO BIOTECH, INC. | Biotechnology | Director/Board Member | |
Aloop Therapeutics ApS
![]() Aloop Therapeutics ApS Pharmaceuticals: MajorHealth Technology Aloop Therapeutics ApS manufactures pharmaceutical preparations. The company is based in Copenhagen, Denmark. The CEOs are Søren Sylvester Skjærbæk, Thomas Kirkegaard Jensen. The Danish company was founded in 2022. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
France | 13 |
Danemark | 11 |
Allemagne | 11 |
Etats-Unis | 8 |
Suisse | 5 |
Sectorielle
Health Technology | 26 |
Finance | 10 |
Consumer Services | 10 |
Commercial Services | 6 |
Consumer Non-Durables | 2 |
Opérationnelle
Director/Board Member | 28 |
Corporate Officer/Principal | 8 |
Chief Executive Officer | 5 |
Chairman | 5 |
Private Equity Investor | 4 |
Relations les plus connectées
- Bourse
- Insiders
- Birgit Jung
- Connexions Sociétés